Understand your NHS customers better
HSJ Intelligence is our expert-driven strategic insights tool. HSJ's unique proximity to the market means that we can leverage our knowledge to help suppliers target the most effective business opportunities, and develop and consolidate sustainable partnerships with the NHS.
Access exclusive strategic insights and data
Our journalists investigate the priorities, unmet needs, performance and capabilities of health systems, and package it all up in easy-to-consume content. With HSJ Intelligence you'll be equipped with the insight and knowledge to foster stronger relationships with NHS partners.
Exclusive insights content on every NHS system
- Easy-to-read ICS profiles and Investigations
- In-depth Briefings on the big picture trends shaping the landscape
- Benefit from over 50 data points that will help benefit your business case
Identify your best opportunities
- Create Watchlist Alerts to keep your team up to date with key partners and prospects
- See Investigations, Leadership, Documents, Spend and more for every system in one place
- Pinpoint opportunities and map your strategy with six powerful insight modules: National, Systems, Organisations, Leadership, Documents, and Spend
Download a sample HSJi Investigation
Using a mixture of proprietary intelligence, HSJ Intelligence brings you the top strategic issues facing specific providers and health systems.
Latest HSJi Review talks about the NHS’s financial crisis
Read Jack Serle's latest HSJi Review, which highlights that the NHS’s finances are in a difficult position but the extent of the crisis, as set out in the latest national briefing on HSJ Intelligence, is still alarming.
The year began with NHS England forcing most of the 42 integrated care systems into setting unrealistic financial targets for 2023-24. Two-thirds of the systems acquiesced to the centre and set breakeven plans, making wildly optimistic assumptions about the inflation rates and how long the doctors’ industrial action would continue. Read full article here.
The integrated care system has a strong history of work at place-level. It is looking to delegate community budgets to acute trusts. It has concerns that funding does not reflect rapid population growth. While parts of Warwickshire are relatively affluent, Coventry is in the worse decile of the cost of living vulnerability Index – which is a sum of work and poverty-based vulnerability indicators for each local authority. Two care collaboratives have been established to oversee health inequality work. Its population health approach will be delivered by primary care networks.
The trust is in a comparatively good position on electives, cancer, diagnostics and emergency care. It is using a host of private providers to reduce elective waiting lists. Its hospital-based diagnostic centre run by a private provider is now operational. Its plans to improve emergency care and patient flow include expanding its virtual ward offer. The trust is falling behind on its plan to break even. Cutting agency spending is key to delivering ambitious efficiency savings.
The NHS spent £19.2bn on medicines in 2022-23, almost exactly an eighth of the total NHS England allocation of £155.1bn. Expenditure has increased by 25 per cent over the preceding seven years as overall demand for medical services has increased, inflationary and supply chain pressures have boosted drug prices, and newer, more expensive drugs have been introduced. NHSE has identified 16 priorities it wants integrated care boards to pursue in their efforts to optimise medicines use. This briefing provides an analysis of the priorities chosen by 35 out of the 42 ICBs.
The following data points were updated last week:
- Main Location, Number Details, Telephone Number of Acute,Sp,Com,MH,Amb in Q3 2023-24
- Leadership of Wales, Scotland in January
- Name, Number of referrals, Patients waiting 36 weeks+ for elective treatment (%), Suspected cancer pathway (open pathways), Patients waiting 14 weeks+ for diagnostics and therapy (%) of Wales in Q3 2023-24
- Beds Occupied, Number of Beds of Acute,Sp,Com,MH in Q3 2023-24
- Bed occupancy of ICS in Q3 2023-24
What our clients say
I use HSJ Intelligence every day to inform the strategic advice that I give to our managers, directors and the board. It has enabled us to connect the dots and grasp opportunities in places that we would have missed before.
Jonathan Wedgbury, CEO, Genmed
The benefit of HSJi is all about bringing the data into one place. There are so many trusts and so many providers, and really understanding how the landscape is changing is so important for suppliers to understand their market. They can do so easily in one place with HSJ Intelligence.
Jo Siddles, Project Manager, Prime plc
I use HSJi to ensure I am up to date with current news about our prospect trusts and their senior personnel. The watchlist facility is useful in that it keeps me appraised of my current engagements and any news about them. This keeps me informed as to current issues and ensures that I am on message when engaging with senior execs with a trust.
Paul Barrett, Strategic sales manager, TeleTracking
Find out more about how HSJ Intelligence can help you
Complete the form below and a member of the team will contact you
With unrivalled access to senior figures, NHS data sources and rigorous primary research, HSJ experts have a unique insight on the NHS, and deep understanding of the strategic issues facing NHS organisations and leadership teams. HSJi offers exclusive, predictive analysis explaining key trends and the specific NHS organisations that are likely to be affected.
Senior insights correspondent